Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OrthoATI versus surgery for severe chronic treatment-resistant lateral epicondylitis
ACTRN12616000458437Phase 2Completed
- Sponsor
- Orthocell
- Start
- Jul 2016
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Ortho ATI in Lateral Epicondylitis (LET) (2 arms), sponsored by Orthocell. Primary endpoint: QuickDASH score. Started Jul 2016; status: completed.
02
Drugs
Ortho ATI
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on ACTRN12616000458437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000458437.